These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32701510)

  • 1. Tubular HIPK2 is a key contributor to renal fibrosis.
    Xiao W; E J; Bao L; Fan Y; Jin Y; Wang A; Bauman D; Li Z; Zheng YL; Liu R; Lee K; He JC
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32701510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-
    Liu R; Das B; Xiao W; Li Z; Li H; Lee K; He JC
    J Am Soc Nephrol; 2017 Jul; 28(7):2133-2143. PubMed ID: 28220029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
    Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
    Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA
    Wang P; Luo ML; Song E; Zhou Z; Ma T; Wang J; Jia N; Wang G; Nie S; Liu Y; Hou F
    Sci Transl Med; 2018 Oct; 10(462):. PubMed ID: 30305452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
    Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
    Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILK participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via TGF-β1/smad pathway.
    Li M; Zhou H; Di J; Yang M; Jia F
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):289-296. PubMed ID: 30657569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
    Jin Y; Ratnam K; Chuang PY; Fan Y; Zhong Y; Dai Y; Mazloom AR; Chen EY; D'Agati V; Xiong H; Ross MJ; Chen N; Ma'ayan A; He JC
    Nat Med; 2012 Mar; 18(4):580-8. PubMed ID: 22406746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.
    Chang X; Zhen X; Liu J; Ren X; Hu Z; Zhou Z; Zhu F; Ding K; Nie J
    Kidney Int; 2017 Sep; 92(3):612-624. PubMed ID: 28318631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.
    Huang Y; Tong J; He F; Yu X; Fan L; Hu J; Tan J; Chen Z
    Int J Mol Med; 2015 Feb; 35(2):311-8. PubMed ID: 25421593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIPK2 C-terminal domain inhibits NF-κB signaling and renal inflammation in kidney injury.
    Feng Y; Li Z; Wang H; Liu BC; Lee K; He JC
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38512421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism.
    Liu Q; Chen X; Kan M; Yang J; Gong Q; Jin R; Dai Y; Jin J; Zang H
    Eur J Pharmacol; 2021 Nov; 910():174501. PubMed ID: 34529980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
    Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
    FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents.
    Hao C; Cao M; Ouyang H; Chen Z; Hu G; Li Q
    Future Med Chem; 2023 Mar; 15(5):453-465. PubMed ID: 37013895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
    Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J
    FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.
    Samarakoon R; Helo S; Dobberfuhl AD; Khakoo NS; Falke L; Overstreet JM; Goldschmeding R; Higgins PJ
    J Pathol; 2015 Aug; 236(4):421-32. PubMed ID: 25810340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.